PMOS: A Fresh Name for PCOS Emphasizing Multisystem Metabolic Roots
PMOS, the official rename of PCOS (polycystic ovarian syndrome), reframes the condition as a multisystem endocrine and metabolic disorder driven largely by insulin resistance, not just ovarian cysts. The Lancet consensus (May 12, 2026) involved about 22,000 experts and 56 organizations to improve diagnosis, reduce stigma, and guide treatment toward metabolic health and personalized care. Diagnosis now emphasizes signs of androgen excess, menstrual history, and metabolic testing, with management focusing on lifestyle changes, glucose control, and targeted therapies, while fertility considerations are addressed when relevant. It is lifelong but manageable with proper care and advocacy.